z-logo
open-access-imgOpen Access
Obesity, Metabolic Syndrome, and Adipocytes
Author(s) -
Michael V. Dodson,
P. S. Mir,
Gary Hausman,
Le Luo Guan,
‬Min Du,
Zhihua Jiang,
Melinda E. Fernyhough,
Werner G. Bergen
Publication year - 2011
Publication title -
journal of lipids
Language(s) - English
Resource type - Journals
eISSN - 2090-3030
pISSN - 2090-3049
DOI - 10.1155/2011/721686
Subject(s) - adipose tissue , metabolic syndrome , obesity , medicine , stromal cell , energy expenditure , adipocyte , endocrinology , bioinformatics , biology
Obesity and metabolic syndromes are examples whereby excess energy consumption and energy flux disruptions are causative agents of increased fatness. Because other, as yet elucidated, cellular factors may be involved and because potential treatments of these metabolic problems involve systemic agents that are not adipose depot-specific in their actions, should we be thinking of adipose depot-specific (cellular) treatments for these problems? For sure, whether treating obesity or metabolic syndrome, the characteristics of all adipose depot-specific adipocytes and stromal vascular cells should be considered. The focus of this paper is to begin to align metabolic dysfunctions with specific characteristics of adipocytes.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom